1. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Issue 10337 (7th May 2022) Authors: Delany-Moretlwe, Sinead; Hughes, James P; Bock, Peter; Ouma, Samuel Gurrion; Hunidzarira, Portia; Kalonji, Dishiki; Kayange, Noel; Makhema, Joseph; Mandima, Patricia; Mathew, Carrie; Spooner, Elizabeth; Mpendo, Juliet; Mukwekwerere, Pamela; Mgodi, Nyaradzo; Ntege, Patricia Nahirya; Nair, Gonasagr... Journal: Lancet Issue: Volume 399:Issue 10337(2022) Page Start: 1779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗